Moneycontrol
HomeNewsBusinessGovt spend will boost infra but concerns around public private partnership not addressed: Vinayak Chatterjee.

Govt spend will boost infra but concerns around public private partnership not addressed: Vinayak Chatterjee.

Vinayak said that the Budget met 7-8 items on his Budget wishlist and the current government has been consistent in its approach to growing the economy through capital investment.

February 03, 2023 / 12:01 IST
Story continues below Advertisement

The central government has emphasised capital expenditure in the economy but it still has not addressed the issues surrounding public-private partnerships in the country, which needs to be urgently looked into, said Vinayak Chatterjee, founder and managing trustee, The Infravision Foundation.

" I am not particularly optimistic (about the sucess of the PPP model in India) because I have not seen any, shall I say, strenuous or concerted attempt to address the ills of PPP, to address the issues that made PPP fall," Chatterjee said.

Story continues below Advertisement

He added that while the Centre’s move to increase capital expenditure on infrastructure in 2023-24 is an encouraging move to drive India’s economy and will push the country’s gross fixed capital formation (GFCF) to be around 7.5-8 percent of GDP in the next financial year,

“Just a year after recovering from the COVID-19 pandemic, if India's GFCF touches 7.5-8 percent in FY24, this is an encouraging sign for the country’s economy,” Chatterjee said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show